Gallbladder Neoplasms clinical trials
The registry lists 248 studies for Gallbladder Neoplasms across more than 10 countries. 59 are recruiting or about to start. Per ClinicalTrials.gov, last updated 2026-09-24.
Status
- Completed
- 109
- Recruiting
- 40
- Status unknown
- 26
- Terminated
- 25
- Active, not recruiting
- 21
- Not yet recruiting
- 14
Phase
- Phase 2
- 114
- Phase 1
- 49
- Phase 3
- 29
- Phase 4
- 2
Where
- United States
- 122
- China
- 49
- Germany
- 21
- United Kingdom
- 21
- Spain
- 15
- France
- 15
Who runs them
National Cancer Institute (NCI) (27) · Shanghai Jiao Tong University School of Medicine (6) · Memorial Sloan Kettering Cancer Center (5) · Alliance for Clinical Trials in Oncology (5) · Mayo Clinic (5) · Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest (4) · M.D. Anderson Cancer Center (4) · Centre Paul Strauss (4)
Studies
Recruiting first, then most recently updated. Showing 50 of 248 — search for more.
- Trifluridine/Tipiracil + Oxaliplatin in Participants With Advanced or Metastatic Biliary Tract CancerRecruitingNCT07146646Phase 21 country
- The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)RecruitingNCT04585750Phase 1/29 countries
- Efficacy and Safety of Zanidatamab With Standard-of-care Therapy Against Standard-of-care Therapy for Advanced HER2-positive Biliary Tract CancerRecruitingNCT06282575Phase 325 countries
- Alternating Chemo-immunotherapy and FGFR Inhibitor for FGFR-positive Biliary or CholangiocarcinomaRecruitingNCT07780838Phase 21 country
- A Study to Learn More About How Well Treatment With Sevabertinib (BAY 2927088) Tablets Works and How Safe it is in Participants Who Have a Solid Tumor With Mutations of the Human Epidermal Growth Factor Receptor 2 (HER2)RecruitingNCT06760819Phase 211 countries
- Phase 2 Study of Daraxonrasib in Recurrent KRAS-Mutant Biliary Tract CancerNot yet recruitingNCT07793253Phase 21 country
- DESTINY-PANTUMOUR04RecruitingNCT071240001 country
- A Study of Rilvegostomig or Durvalumab Plus Chemotherapy for First-Line Treatment of Biliary Tract Cancer (ARTEMIDE-Biliary02)RecruitingNCT07221253Phase 319 countries
- AK112 Combined With GAP Conversion Therapy for Locally Advanced Gallbladder CancerNot yet recruitingNCT07767994Phase 2
- Distance-Based Exercise to Preserve Function and Prevent DisabilityRecruitingNCT07059884Not applicable1 country
- Pressurized Intraperitoneal Aerosolized Nab-Paclitaxel in Combination With Gemcitabine and Cisplatin for the Treatment of Biliary Tract Cancer Patients With Peritoneal MetastasesRecruitingNCT05285358Phase 11 country
- IKS04 Regimen in Advanced Solid Tumors That Express CA242Not yet recruitingNCT07738939Phase 11 country
- Atezolizumab Plus Tivozanib in Immunologically Cold Tumor TypesRecruitingNCT05000294Phase 1/21 country
- Locally ablatIVe thErapy for oLigo-progressive gastrOintestiNal maliGnancies (LIVELONG)RecruitingNCT06101277Not applicable1 country
- A Study to Select a Dose Regimen (Part A) and to Investigate Overall Survival (Part B) With Nanvuranlat Compared With Physician's Best Choice in Participants Aged 18 Years or Older With Biliary Tract CancerRecruitingNCT07265674Phase 31 country
- Integrated Cancer Repository for Cancer ResearchRecruitingNCT020126991 country
- Efficacy and Safety of Postoperative Concurrent Chemoradiotherapy for Extrahepatic Cholangiocarcinoma and Gallbladder Carcinoma: A Multicenter Prospective Phase II StudyRecruitingNCT07636824Phase 21 country
- Dual-Target HER2/CEA CAR-NK Cells in Advanced Biliary Tract CancerRecruitingNCT07641036Phase 1/21 country
- A Phase II Study of GV20-0251 in Combination With Anti-PD-1 Monoclonal Antibodies in Patients With Unresectable, Locally Advanced, or Metastatic Solid Tumors.Not yet recruitingNCT07623642Phase 21 country
- Safety and Efficacy of CD160-Enhanced Autologous Antigen-Specific T-Cells (BTC-Ag-T) in Advanced Biliary Tract CancerRecruitingNCT07614061Phase 11 country
- To Evaluate the Safety, Tolerability, and Preliminary Efficacy of XH001 Injection as Adjuvant Therapy in Patients With High-risk Recurrent Solid TumorsRecruitingNCT07594964Phase 11 country
- Outcomes After Liver and Biliary Resection at a High-Volume CenterNot yet recruitingNCT075568351 country
- Agnostic Therapy in Rare Solid TumorsRecruitingNCT06638931Phase 21 country
- TRACE-BTC. Relation of Biomarkers and Patients Reported Quality of Life to Outcomes in Patients With Biliary Tract Cancer: a Real- World CohortNot yet recruitingNCT074544861 country
- Virtual Reality for GI Cancer Pain to Improve Patient Reported OutcomesRecruitingNCT04907643Not applicable1 country
- EULAT Eradicate GBCRecruitingNCT061927195 countries
- Prospective Evaluation of 68Ga-FAPI PET in Biliary CancersRecruitingNCT073378501 country
- Target-specific immunoPET Imaging of Digestive System CarcinomaRecruitingNCT06715839Not applicable1 country
- Gemcitabine and Nab-Paclitaxel Combined With Iparomlimab and Tuvorilimab for Advanced Gallbladder CancerEnrolling by invitationNCT07310069Phase 21 country
- A Phase IIb Randomized Clinical Trial of Immune Checkpoint Inhibitor-based Maintenance Therapy in Patients With Advanced Biliary Tract CancerNot yet recruitingNCT07269158Phase 1/21 country
- DETERMINE Trial Treatment Arm 04: Trastuzumab in Combination With Pertuzumab in Adult, Paediatric and Teenage/Young Adult Patients With Cancers With HER2 Amplification or Activating MutationsRecruitingNCT05786716Phase 2/31 country
- Study of ACC-1898 in Adult Participants With Advanced Solid TumorsNot yet recruitingNCT07252661Phase 1
- A Cell-free DNA Methylation Blood-Based Test for Biliary Tract Cancers ScreeningRecruitingNCT071769621 country
- STALL vs Sole Local Wound Infiltration in Laparoscopic CholecystectomyRecruitingNCT06123117Not applicable1 country
- Robotic-assisted Contra Open Resection for Suspected or Confirmed Gallbladder Cancer (ROBOCOP)RecruitingNCT06246448Not applicable1 country
- Sequential Anti-Angiogenic Therapy After Immunotherapy in Advanced Biliary Tract CancerRecruitingNCT07025174Phase 21 country
- Bile Omics for Diagnosing Indeterminate Biliary StricturesRecruitingNCT070078321 country
- Gem+Nab-P+LEN+TIS for Advanced Unresectable BTC (GALENT-BT)Enrolling by invitationNCT06963060Phase 21 country
- Neoadjuvant Chemotherapy for Locally Advanced Gall Bladder Cancer : a Randomized Control Trial (NEOGB)RecruitingNCT06712420Phase 31 country
- Radiation Therapy in Unresectable Gall Bladder CancerRecruitingNCT06214572Phase 2/31 country
- Camrelizumab and Chemotherapy With or Without Anlotinib as First-line Treatment for Advanced Gallbladder Cancer and Extrahepatic CholangiocarcinomaEnrolling by invitationNCT06901622Phase 21 country
- Phase II Clinical Study of GemOX Hepatic Arterial Infusion Combined with Lenvatinib and Toripalimab for Advanced and Unresectable Intrahepatic Cholangiocarcinoma and Gallbladder CancerRecruitingNCT06852287Phase 21 country
- Proteomic Analysis of Patients Undergoing Bariatric SurgeryNot yet recruitingNCT06787807Not applicable1 country
- Primary Percutaneous Stenting Above the Ampulla Versus Endoscopic Drainage for Unresectable Malignant Hilar Biliary ObstructionEnrolling by invitationNCT06671418Phase 31 country
- Target Therapy With GEMOX in Recectable Gallbladder Carcinoma Patients Monitored by ctDNARecruitingNCT04183712Phase 21 country
- A Single-arm Phase II Clinical Study of the Efficacy and Safety of Camrelizumab Combined With GEMOX for Unresectable GBCsRecruitingNCT06423170Phase 21 country
- Quebec Pancreas Cancer StudyRecruitingNCT041042301 country
- Construction of Multicenter Retrospective Registry Cohort Database for Gallbladder CancerNot yet recruitingNCT06276153
- Combination Therapy of HAIC, Surufatinib and Tislelizumab for Unresectable or Metastatic Biliary Tract CancerNot yet recruitingNCT06134193Phase 2
- Robot-assisted vs Laparoscopic vs Open Radical Cholecystectomy for Gallbladder CancerEnrolling by invitationNCT060617441 country